Precision Medicine

Comprehensive TPMT Genotyping Urged To Predict Thiopurine Drug Response
Research & Development Comprehensive TPMT Genotyping Urged To Predict Thiopurine Drug Response

Mayo Clinic researchers have made a case for comprehensive TPMT genotyping across various ancestries to better predict drug response and minimize adverse reactions. Their recent discovery of the TPMT∗8 allele, a gene variant associated with reduced metabolism of thiopurine drugs, has revolutionary

How Can We Combat the Global Genital Herpes Health Crisis?
Research & Development How Can We Combat the Global Genital Herpes Health Crisis?

Genital herpes continues to be a significant global health issue, affecting millions of individuals worldwide. Despite the high prevalence, the condition often remains under-discussed and inadequately addressed. While many individuals exhibit no or few symptoms, others suffer from painful genital

Can High-Fructose Corn Syrup Fuel Cancer Growth and Spread?
Research & Development Can High-Fructose Corn Syrup Fuel Cancer Growth and Spread?

The relationship between dietary fructose, particularly from high-fructose corn syrup, and cancer growth is a topic of growing concern. Over the past few decades, the consumption of high-fructose corn syrup has skyrocketed. While naturally occurring fructose in fruits, vegetables, and honey is

Patient-Derived Glioblastoma Organoids Advance Personalized CAR-T Therapy
Tech & Innovation Patient-Derived Glioblastoma Organoids Advance Personalized CAR-T Therapy

Researchers at the Perelman School of Medicine at the University of Pennsylvania have made a significant breakthrough in personalized medicine and cancer treatment. By using patient-derived glioblastoma (GBM) organoids, they have developed a method to model patient responses to CAR-T cell therapy

Certis Oncology Launches AI Chatbot to Boost Cancer Research Efficiency
Research & Development Certis Oncology Launches AI Chatbot to Boost Cancer Research Efficiency

Certis Oncology Solutions has introduced a groundbreaking innovation: the CertisOI Assistant™, an AI-powered chatbot aimed at significantly enhancing the efficiency of preclinical oncology research. Leveraging the capabilities of artificial intelligence, machine learning (AI/ML), and OpenAI’s

Repurposed Drug Selinexor Shows Promise for Treating KRAS Mutant NSCLC
Research & Development Repurposed Drug Selinexor Shows Promise for Treating KRAS Mutant NSCLC

Recent advances in the fight against non-small cell lung cancer (NSCLC) have brought new hope for patients carrying KRAS mutations, thanks to a breakthrough discovery by researchers at UT Southwestern Harold C. Simmons Comprehensive Cancer Center. This advancement revolves around the repurposing of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later